ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Ocean Biomedical Inc

Ocean Biomedical Inc (OCEA)

0,54
-0,034
(-5,92%)
Fermé 20 Janvier 10:00PM
0,5355
-0,0045
(-0,83%)
Après les heures de négociation: 1:50AM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
0,5355
Prix Achat
0,53
Prix Vente
0,749
Volume échangé
108 526
0,5301 Fourchette du Jour 0,600399
0,4603 Plage de 52 semaines 7,79
Cap du marché
Clôture Veille
0,574
Ouverture
0,574
Dernière Transaction
475
@
0.5355
(formt)
Dernière heure de transaction
Volume financier
US$ 59 279
VWAP
0,546217
Volume moyen (3 m)
245 708
Actions en circulation
34 868 628
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-3,03
Bénéfice par action (BPA)
-3,28
Chiffre d'affairess
-
Bénéfice net
-114,47M

À propos de Ocean Biomedical Inc

Aesther Healthcare Acquisition Corp is a newly-organized blank check company. It is formed for the purpose effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Aesther Healthcare Acquisition Corp is a newly-organized blank check company. It is formed for the purpose effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Dover, Delaware, USA
Fondé
-
Ocean Biomedical Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker OCEA. Le dernier cours de clôture d'Ocean Biomedical était de US$0,57. Au cours de la dernière année, les actions de Ocean Biomedical ont été négociées dans une fourchette de prix de US$ 0,4603 à US$ 7,79.

Ocean Biomedical compte actuellement 34 868 628 actions en circulation. La capitalisation boursière d'Ocean Biomedical est de US$20,01 million. Ocean Biomedical a un ratio cours/bénéfice (ratio PE) de -3.03.

OCEA Dernières nouvelles

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

PROVIDENCE, Rhode Island, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on November 18, 2024, it received a notice from The Nasdaq Stock Market...

Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter

PROVIDENCE, Rhode Island, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on October 16, 2024, it received a Staff Determination Letter from The...

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses

Ocean Biomedical’s Anti-CHI3L1 patent coverage includes multiple methods of use for targeting a broad range of Cancers that include Lung Cancer, Glioblastoma, Prostate Cancer, Melanoma, and Breast...

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms

Providence, RI, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ:OCEA) announced today that its Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been issued a key U.S. patent...

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

PROVIDENCE, Rhode Island, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on August 19, 2024, it received a notice from The Nasdaq Stock Market LLC...

Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024

Providence, RI, June 05, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research...

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

PROVIDENCE, Rhode Island, May 30, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on May 22, 2024, it received a notice from The Nasdaq Stock Market...

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease

Providence, RI, May 16, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ:OCEA) announced today that Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been granted a new patent for his...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.1145-17.61538461540.650.70090.53551293990.6172534CS
4-0.0191-3.44392354850.55460.7534550.46037098340.6585549CS
12-0.4644-46.44464446440.99990.99990.46032457080.66839438CS
26-0.7145-57.161.251.450.46031442960.76914769CS
52-0.0598-10.04535528310.59537.790.460318206622.92951288CS
156-9.4245-94.62349397599.9626.59860.460315631914.66766429CS
260-9.4245-94.62349397599.9626.59860.460315631914.66766429CS

OCEA - Frequently Asked Questions (FAQ)

What is the current Ocean Biomedical share price?
The current share price of Ocean Biomedical is US$ 0,5355
How many Ocean Biomedical shares are in issue?
Ocean Biomedical has 34 868 628 shares in issue
What is the market cap of Ocean Biomedical?
The market capitalisation of Ocean Biomedical is USD 20,01M
What is the 1 year trading range for Ocean Biomedical share price?
Ocean Biomedical has traded in the range of US$ 0,4603 to US$ 7,79 during the past year
What is the PE ratio of Ocean Biomedical?
The price to earnings ratio of Ocean Biomedical is -3,03
What is the reporting currency for Ocean Biomedical?
Ocean Biomedical reports financial results in USD
What is the latest annual profit for Ocean Biomedical?
The latest annual profit of Ocean Biomedical is USD -114,47M
What is the registered address of Ocean Biomedical?
The registered address for Ocean Biomedical is 8 THE GREEN, STE A, KENT, DOVER, DELAWARE, 19901
What is the Ocean Biomedical website address?
The website address for Ocean Biomedical is www.aestherhealthcarespac.com
Which industry sector does Ocean Biomedical operate in?
Ocean Biomedical operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BTCTBTC Digital Ltd
US$ 8,2697
(73,73%)
61,45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8,80
(62,36%)
18,63M
CRKNCrown Electrokinetics Corporation
US$ 0,1235
(54,96%)
764,86M
NUKKNukkleus Inc
US$ 29,97
(45,98%)
19,09M
GSITGSI Technology
US$ 3,97
(44,36%)
87,7M
DOGZDogness International Corporation
US$ 18,23
(-58,77%)
740,45k
ORKTOrangeKloud Technology Inc
US$ 3,02
(-24,88%)
21,08M
PMAXPowell Max Ltd
US$ 0,6364
(-23,31%)
4,17M
LGCBLinkage Global Inc
US$ 0,2876
(-22,27%)
890,66k
YYAIConnexa Sports Technologies Inc
US$ 0,8299
(-20,20%)
602,48k
CRKNCrown Electrokinetics Corporation
US$ 0,1235
(54,96%)
764,86M
GCTKGlucoTrack Inc
US$ 0,0852
(15,45%)
465,22M
RIMEAlgorhythm Holdings Inc
US$ 0,0406
(-4,02%)
387,23M
TGLTreasure Global Inc
US$ 0,2459
(14,75%)
267,1M
NVDANVIDIA Corporation
US$ 137,71
(3,10%)
201,4M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock